Neoplastic Diseases




(1)
Department of Dermatology, University of Pennsylvania, Penn Presbyterian Medical Center Medical Arts Building, Philadelphia, PA, USA

 




Abstract

Cutaneous neoplasms are either growths of cells normally in the skin or growths of cells that have abnormally migrated to the skin. Most neoplastic diseases fall under the dermal reaction pattern, but since it is such a large category, it is separated into its own section. Here neoplasms and tumors are divided by the type of proliferation.


Keywords
Skin neoplasmsSkin tumors



7.1 Keratinocyte Neoplasms






  • Normally occurring cells of the epidermis include: keratinocytes, melanocytes, Langerhans cells, neuroendocrine cells

    1.

    Benign keratinocyte neoplasms/hyperplasias

    (a)

    Seborrheic keratosis



    • Path: flat-topped papillomatous epidermis, horned pseudocysts


    • See also Keratotic Diseases: Hyperkeratotic Eruptions

     

    (b)

    Benign lichenoid keratosis



    • Aka lichen planus-like keratosis (LPLK)


    • See also Keratotic Diseases: Hyperkeratotic Eruptions

     

    (c)

    Epidermal nevi



    • See also Keratotic Diseases: Hyperkeratotic Eruptions

     

    (d)

    Warts



    • HPV-induced keratinocyte proliferations including verruca vulgaris and condyloma acuminata


    • See also Infectious Diseases: Viral:DNA Viruses: Papovavirus

     

    (e)

    Warty dyskeratoma



    • Papule of focal acantholytic dermatosis


    • See also Vesiculobullous Diseases: Intraepidermal Blisters

     

    (f)

    Clear cell acanthoma/Pale cell acanthoma



    • On path, can appear very similar to psoriasis, except cells notably pale (from glycogen), and clinically it is usually a solitary

     

    (g)

    Chondrodermatitis nodularis helicis (CNH)



    • Chronic tender ulcerated nodule on helix of ear, ddx BCC and SCC


    • From pressure/friction, not a neoplasm


    • See also Keratotic Diseases: Lichen Simplex

     

     

    2.

    Premalignant keratinocyte neoplasms

    (a)

    Actinic keratosis (AK)



    • Aka solar keratosis


    • Path: partial-thickness keratinocyte atypia (starting at basement membrane), parakeratosis that spares areas over adnexae


    • For each AK, apparently 2–10 % chance of progression to SCC


    • On lips, can see actinic cheilitis/cheilosis (lower > upper lip)

     

    (b)

    Bowenoid papulosis



    • May represent an intermediate between condyloma and SCCIS


    • Papular HPV lesions most commonly on the penis that may have malignant potential


    • Most associated with HPV-16, 18

     

    (c)

    Leukoplakia



    • Cannot be removed (unlike thrush)


    • Associated with tobacco (smoked and chewed) and alcohol


    • This is different from oral hairy leukoplakia, which is caused by EBV, but has no malignant potential, and may be a sign of HIV infection


    • One type seen in dyskeratosis congenita, see also Vascular: Regional Erythema:Telangiectasia: Genodermatoses with early aging, telangiectasia, sun sensitivity

     

     

    3.

    Malignant keratinocyte neoplasms



    • Note: Collectively, squamous cell carcinomas and basal cell carcinomas are referred to as non-melanoma skin cancers (NMSCs). Others have used the term “keratinocyte carcinoma,” which may be a more specific and accurate term.




    • Note: in transplant/immunosuppressed patients, see increase in skin cancers estimated at: SCC (65X), BCC (5X), and MM (3X); SCC, by far, accounts for most. In HIV, skin cancer risk is increased, but at a much lower factor.


    (a)

    Basal cell carcinoma (BCC)



    • BCC is the most common cause of skin cancer in Caucasians and East Asians; most common cancer of all organs overall


    • Clinically, may see pearly papule, ulcer with “rolled borders,” dermoscopy with “arborizing vessels”


    • Gene most frequently mutated = PTCH (on Chr 9q)


    • PTCH’s product = Patched, the transmembrane sonic hedgehog (Shh) receptor); normally hedgehog regulates Patched, which inhibits Smoothened (SMO, a proto-oncogene). Thus, Patched inactivation mutation and Smoothened activation mutations would constitutively activate expression, causing BCCs.


    • Other mutated relevant genes may include p53, MCR1


    • Path = basaloid growth, nuclear debris, mucinous stroma, peripheral palisading clefting/retraction; ddx trichoepithelioma, MAC


    • Metastases in <0.55 %


    • Surgical excision of BCCs: < 2 cm = 3–4 mm margin, ≥2 cm = 6 mm margin or Mohs surgery


    • Evidence says imiquimod and 5-FU may be used as monotherapy for superficial BCC; limit these topicals to low-risk areas, and not for other types of BCC


    Types:

    I.

    Superficial/Superficial multifocal

     

    II.

    Nodular

     

    III.

    Pigmented

     

    IV.

    Sclerosing



    • Aka morpheaform or sclerodermiform


    • Clinically may resemble a scar


    • Considered a more aggressive form of BCC; may extend farther histologically than is appreciable clinically

     

    V.

    Fibroepithelioma of Pinkus



    • Large tumor in lumbosacral area; may appear tag-like


    • Path: thin strands of anastamosing basal cells

     

    VI.

    Infundibulocystic



    • Controversial if different from basaloid follicular hamartoma

     

    VII.

    Syndromes that cause BCCs



    • See also Neoplastic: Syndromes with multiple tumors or multiple types of tumors


    1.

    BCC nevus syndrome



    • Aka Gorlin’s syndrome/Gorlin-Goltz/nevoid BCC syndrome


    • Multiple BCCs at young age, other tumors, congenital abnormalities including odontogenic keratocysts of the jaw, calcification of falx cerebri, palmar pits, ovarian fibromas (4–24 % of women)


    • Can be associated with medulloblastoma


    • PTCH (Patched) gene mutation, autosomal dominant

     

    2.

    Bazex-Dupré-Christol syndrome



    • Note: do not confuse with acrokeratosis paraneoplastica (also called Bazex syndrome)




    • Genodermatosis of follicular atrophoderma and the early onset of multiple BCCs, may have hypohidrosis


    • X-linked dominant

     

    3.

    Rombo syndrome



    • Similar to Bazex, but with KP-like lesions of cheeks that can form honeycombed, worm-eaten appearance (atrophoderma vermiculatum)


    • Hypotrichosis but not hypohidrosis (mnemonic Rambo must sweat), blepharitis, milia (break down into atrophoderma), peripheral vasodilation with cyanosis, BCCs

     

    4.

    Multiple hereditary infundibulocystic BCC syndrome



    • Several cases reported

     

     

     

    (b)

    Squamous cell carcinoma (SCC)



    • Primary risk factors: UV, HPV


    • Most common mutation = p53 (Chr 17). Others include CDKN2A and PTCH


    • Can occur at sites of chronic trauma/ulcers, scars (Marjolin’s ulcer), chronic inflammation (e.g. lichen planus, lichen sclerosus, discoid lupus), radiation, or chemical exposure


    • Arsenic is a well-defined cause of SCC; may see palmoplantar arsenical keratoses, multiple tumors as clue


    • SCC is the most common cause of skin cancer in African-Americans and Asian Indians; may be more aggressive


    • High-risk SCC generally defined as >2 cm diameter, >4 mm thickness, recurrent, high-grade or desmoplastic growth, presence of perineural invasion, certain high-risk locations (ear/near parotid gland, nose, lip, perianal, genital), immunosuppression (especially with organ transplant), lymphovascular invasion


    • Metastatic risk for SCC estimated at 0–10 %


    • Path = full-thickness keratinocyte atypia with invasion


    • Surgical excision of SCCs: generally, low-risk = 3–4 mm margin, high risk = 6 mm margin or Mohs surgery

     

    (c)

    Squamous cell carcinoma in situ (SCCIS)



    • Path = full-thickness keratinocyte atypia, confined by basement membrane; parakeratosis; may have loss of polarity (meaning that the superficial and deeper epidermis can no longer be distinguished), loss of proper maturation


    • Evidence says topical 5-FU may be used as monotherapy; limit topicals to low-risk areas, and not for invasive SCC


    I.

    Bowen’s disease



    • Some use the term “Bowen’s” to refer only to SCCIS on the penis, and others use the term Bowen’s as synonymous with all SCCIS

     

    II.

    Erythroplasia of Queyrat



    • Bowen’s disease on the glans penis

     

    III.

    Erythroplakia



    • Like erythroplasia of Queyrat, but in the mouth

     

     

    (d)

    Keratoacanthoma (KA)



    • Clinical: cutaneous horn, Path: keratin-filled crater/keratotic plug surrounded by proliferation of atypical keratinocytes/mitoses


    • Usually considered a form of SCC or benign with a small risk of progression to invasive SCC


    • Typical history = sudden onset (weeks)


    • Should regress on own, but usually treated as SCC


    I.

    Muir-Torre syndrome



    • Subtype of hereditary nonpolyposis colorectal cancer (HNPCC) syndrome (aka Lynch syndrome), prone to colon, breast, GU cancers


    • Sebaceous neoplasms (adenoma, epithelioma, or carcinoma), keratoacanthomas, and internal malignancies; sebaceous adenoma is a unique hallmark


    • Mutations in MSH2, MLH1 (DNA mismatch repair gene)


    • See also Neoplastic/Tumors: Syndromes with multiple tumors or multiple types of tumors

     

    II.

    Ferguson-Smith syndrome



    • Multiple spontaneously regressing KAs in sun-exposed areas, autosomal dominant

     

    III.

    Grzybowski syndrome



    • Generalized eruptive KAs, thousands of papules resembling milia

     

    IV.

    Side effect of BRAF inhibitors



    • Multiple eruptive keratoacanthomas and SCCs have been reported in association with BRAF inhibitors in treatment for metastatic melanoma

     

     

    (e)

    Verrucous carcinoma



    • A well-differentiated variant of SCC that is large, and pale and glassy on pathology; not simply an SCC with a warty appearance


    1.

    Giant condyloma acuminata (Buschke-Löwenstein tumor)



    • Large, locally destructive verrucous plaque, usually on penis > other anogenital


    • May be associated with HPV-6, 11

     

    2.

    Oral florid papillomatosis (Ackerman tumor)



    • Warts in oral cavity, nasal sinuses


    • May be promoted by smoking, radiation

     

    3.

    Epithelioma cuniculatum



    • Verrucous carcinoma arising from a plantar wart on the foot

     

     

    (f)

    Adenoid SCC (pseudoglandular)



    • May have acantholysis, so remember to consider acantholytic SCC in ddx of herpes and acantholytic dermatoses (e.g. pemphigus)

     

     


7.2 Melanocytic Neoplasms




1.

Benign melanocytic neoplasms

(a)

Common acquired melanocytic nevi



  • Nests of melanocytes, predominantly in rete ridges


  • On path: remember to evaluate size, symmetry, circumscription; need full lesion (shave or excision)

    I.

    Intradermal nevus



    • Nest of melanocytes in dermis


    • Clinically usually exophytic


    • Clinical ddx acrochordon, neurofibroma

     

    II.

    Compound nevus



    • Nests of melanocytes in epidermis and dermis


    • Path: center with melanocytes in dermis/junction, may have surrounding rim of junctional melanocytes = shouldering (creates fried egg appearance clinically)

     

    III.

    Junctional nevus



    • Nests of melanocytes at D-E junction


    • Clinically macular

     

    IV.

    Recurrent nevus



    • Recurrence after biopsy or excision, may look more concerning given altered appearance


    • Path: melanocytic proliferation over a scar

     

    V.

    Acral nevi



    • Benign dermoscopic patterns = parallel furrow (most common), lattice-like, and fibrillar patterns


    • Concerning dermoscopic patterns include parallel ridge and multicomponent

     

 

(b)

Dysplastic/atypical nevus



  • Aka Clark’s nevus


  • On path, these characteristics may be seen:

    1.

    Bridging of rete ridges

     

    2.

    Shouldering

     

    3.

    Lamellar fibroplasia (fibrosis around basement membrane)

     

    4.

    Slight atypia

     


  • Other atypical features include asymmetry, poor circumscription, Pagetoid spread


  • Recent description of nevi with features of Spitz and dysplastic (Clark’s) nevi was called “Spark’s nevus”


  • In general, dysplastic nevi are not considered premalignant lesions. They represent a patient risk factor for melanoma and are re-excised less because of concern that they will evolve into a melanoma and more because of concern that a melanoma diagnosis was missed.


  • Typically, DNs are reported as having mild, moderate, or severe atypia; the risk of melanomas being misclassified as mild or moderate DNs appears to be extremely small to none. Severe DNs are uniformly re-excised (as they are borderline to MMIS). However, many are comfortable (and some evidence supports) not re-excising mild and moderate DNs, especially if margins were clear on biopsy.


I.

“Dysplastic nevus syndrome”



  • Patients with multiple DNs with increased risk for MM; not a well-defined syndrome

 

II.

Familial atypical multiple mole melanoma (FAMMM) syndrome



  • An autosomal dominant disease, from mutation in CDKN2A (or p16) gene, or CDK4 gene


  • Predisposition to >50 atypical nevi and multiple melanomas


  • 70 % will develop at least one melanoma, 30 % will have multiple


  • Increased risk for pancreatic cancer (20X), with lifetime risk of 15–20 %

 

 

(c)

Congenital melanocytic nevus



  • Small <1.5 cm, Medium = 1.5–20 cm


  • Large/giant >20 cm (or >5 % TBSA in prepubertal), can have “bathing trunk” distribution


  • Path: “congenital pattern” = wraps around adnexal structures


  • Increased risk of MM, neurocutaneous melanosis (NCM) = syndrome of large congenital melanocytic nevi with meningeal melanosis or melanoma


  • Greatest risk for NCM in axial lesions with satellite nevi, screen with MRI


  • 50 % with NCM get leptomeningeal MM

 

(d)

Spitz nevus



  • Aka “benign juvenile melanoma”


  • In kids, clinical ddx JXG, mastocytoma


  • Dermoscopy: starburst pattern


  • Path: circumscribed elongated nests (may look like bananas), separated from adjacent keratinocytes (clefting around nests), with Kamino bodies (pink globules)


  • Many Spitz have HRAS mutation associated


  • “Spitzoid features” of other nevi include: nests that are vertical, epithelioid appearance, spindle cells

 

(e)

Pigmented spindle cell nevus of Reed



  • Classically a recently developed well-circumscribed black lesion on thigh of young woman (without other pigmented lesions on body)


  • Some classify this as a subtype of Spitz nevus


  • Path: fascicles of uniform, slender spindle cells with melanin

 

(f)

Deep penetrating nevus



  • Aka plexiform spindle cell nevus


  • Dark papule/nodule typically on head/neck in first few decades


  • Path: sharply demarcated wedge-shaped pigmented proliferation


  • Shares features with both Spitz nevi and blue nevi, and can mimic melanoma

 

(g)

Halo nevus



  • A nevus with a surrounding white halo, caused by an immune response to nevus cells (infiltrating lymphocytes on path); repigments if remove nevus

 

(h)

Balloon cell nevus



  • Variant of nevus with predominance of altered, large melanocytes with vacuolated cytoplasm

 

(i)

Becker’s nevus/melanosis



  • Unilateral, hyperpigmented patch, often with hypertrichosis


  • On path, acanthosis, features of smooth muscle hamartoma, basilar hyperpigmentation; ddx accessory nipple (papillomatous)


  • See also Neoplastic: Spindle Cell Tumors: Smooth Muscle

 

(j)

Nevus spilus



  • Speckled lentiginous nevus


  • Can see in phakomatosis pigmentovascularis (with capillary malformation), phakomatosis pigmentokeratotica (with nevus sebaceus)

 

(k)

Dermal melanocytosis

Note: Melanocytes may remain in dermis (stalled migration from neural crest during in utero development) most commonly in three areas: head/neck, lumbosacral, distal dorsal extremities

I.

Mongolian spot



  • On lumbosacral


  • Multiple can be associated with lysosomal storage diseases

 

II.

Nevus of Ota



  • By eye


  • Laser tx = q-switched Ruby or Alexandrite

 

III.

Nevus of Ito



  • On shoulder

 

IV.

Acquired dermal melanocytosis



  • Not congenital; might represent reactivation of existing dermal melanocytes

 

V.

Blue nevus (dermal melanocytoma)



  • GNAQ mutations may be associated

    1.

    Common blue nevus



    • Path: elongated, wavy melanocytes, melanophages

     

    2.

    Cellular blue nevus



    • Path: dendritic melanocytes associated with nests of spindle cells


    • Atypical cellular blue nevi hard to distinguish from melanoma

     

 

 

l.

Lentigines (lentigo simplex)



  • Increased number of melanocytes and melanin (but not a neoplastic proliferation)


  • Essentially the same as café-au-lait macules, but <5 mm


  • Labial lentigo: path = mucosal, ectatic, broad rete ridges, basilar hyperpigmentation




  • Can be seen in many syndromes:

    I.

    Peutz-Jeghers syndrome



    • Perioral and oral mucosal lentigines prominent


    • Intestinal polyposis, risk of intussusseption


    • Mutation in STK11 (LKB1), a serine-threonine kinase


    • Increased cancers (93 % have cancer, 50 % have died from cancer by age 57!), especially GI cancers, breast, ovarian

     

    II.

    Laugier-Hunziker syndrome



    • Only lentigines, no other findings or risks

     

    III.

    LEOPARD syndrome



    • Lentigines, Electrocardiographic conduction defects, Ocular hypertelorism, Pulmonary stenosis, Abnormalities of genitalia, Retardation of growth and Deafness (need lentigines and ≥2 others for dx)


    • Autosomal dominant, PTPN11 gene; defect in same gene causes Noonan syndrome

     

    IV.

    Carney complex



    • Aka LAMB/NAME syndrome


    • Lentigines, Atrial myxoma, Mucocutaneous myxoma, Blue nevi


    • Nevi, Atrial myxoma, Myxoid neurofibroma, Ephelides


    • Essentially 3 main components: 1. Myxomas (skin, heart, breast), 2. Lentigines (spotty skin pigmentation), 3. Endocrine tumors/abnormalities


    • Associated with PRKAR1A gene mutation (tumor suppressor gene that encodes a cAMP-dependent kinase important in many endocrine processes), autosomal dominant – Less common components include large-cell calcifying Sertoli cell tumor of the testis (sexual precocity), psammomatous melanotic schwannoma, epithelioid blue nevus. Also, growth hormone-producing pituitary adenomas.

     

    V.

    Cronkhite-Canada syndrome



    • Polyposis associated with lentigines of buccal mucosa, face, acral sites; nail dystrophy, alopecia


    • Usually in older men

     

 

(m)

Café-au-lait macules (CALMs)



  • Essentially the same as lentigines, but >5 mm


  • Path: increased melanin/melanosomes, but not increased melanocytes


I.

Neurofibromatosis – types I and II



  • “Coast of California”-type CALMs


  • Axillary freckling “Crowe’s sign”


  • Dx criteria for NF require ≥6 CALMs of 5 mm (prepubertal) 1.5 cm (postpubertal)


  • See also Neoplastic: Syndromes with Multiple Tumors or Multiple Types of Tumors

 

II.

McCune-Albright syndrome



  • Precocious puberty and CALMs


  • “Coast of Maine”-like CALMs

 

 

(n)

Solar lentigines (liver spots/solar lentigo)



  • See in older patients; may be precursors for macular seborrheic keratoses


  • From UV exposure


  • Path: club-shaped rete ridges with pigmentation, solar elastosis

 

(o)

Ephelides (freckles)



  • Only in sun-exposed areas, can see in kids

 

 

2.

Malignant melanocytic neoplasms

(a)

Melanoma (MM)



  • Melanoma represents less than 2 % of skin cancers, but accounts for the majority of skin cancer deaths (about 10,000/year)


  • Sixth most common cancer diagnosis in US and the most common cancer in Caucasian women age 25–29


  • Path: atypical features as described in dysplastic nevi, neoplastic proliferation of melanocytes beyond nests, Pagetoid spread, artifactual splitting in epidermis from lack of cellular adhesions (desmosomes) with melanocyte infiltrate, regression


  • Risk factors include: exposure to sun (intermittent sun exposure significant rather than total sun exposure seems more important), use of sun beds/tanning bed, skin phenotype/pigmentation (Fitzpatrick skin type), number of melanocytic nevi and dysplastic nevi, family history of melanoma, personal history of melanoma


  • Despite association of melanoma with ultraviolet radiation (exemplified by xeroderma pigmentosum with defects in nucleotide excision repair), it is not clear how UVR causes melanoma; melanomas lack the UVB signature mutations seen in NMSCs. It is clear, however, that melanoma can occur without sun exposure.


  • Most melanomas occur de novo; less than 1/4 in association with nevi; dysplastic nevi no more likely to develop MM than other common nevi


  • Breslow depth (from top of granular layer to deepest point) relates to prognosis; Clark level was another measure of depth that was found to be poorly reproducible and thus has fallen out of favor


  • Hutchinson’s sign = melanonychia with pigment on proximal nail fold, suggestive of melanoma


  • 2010 AJCC criteria (T/N/M staging):

 




  • Tis = MMIS



    • T1 <1 mm thickness

      (a)

      without ulceration and mitosis <1/mm2

       

      (b)

      with ulceration or mitoses ≥1/mm2

       


    • T2 1.01–2.00 mm thickness

      (a)

      without ulceration

       

      (b)

      with ulceration

       


    • T3 2.01–4.00 mm thickness

      (a)

      without ulceration

       

      (b)

      with ulceration

       


    • T4 >4.00 mm thickness

      (a)

      without ulceration

       

      (b)

      with ulceration

       


    • N1 a: Micrometastasis, b: Macrometastasis




  • Staging:



    • Stage 0 = Tis, N0, M0


    • Stage IA = T1a; IB = T1b, T2a;


    • Stage IIA = T2b, T3a; IIB = T3b, T4a; IIC = T4b


    • Stage III = any T, N > N0, M0


    • Stage IV = any T, any N, M1




  • Increased LDH signifies poor prognosis


  • In-transit metastases are defined as lesions >2 cm from primary tumor, but not to the nodes


  • Satellite lesions are lesions within 2 cm of primary tumor; local recurrence typically defined as lesion within 2 cm of surgical scar


  • Sentinel lymph node biopsy controversial; quickly becoming standard of care since informs staging, but no mortality benefit to patients found; generally considered in stage III, IV, and even in any tumor with Breslow depth >1 mm


  • CDKN2A (Chr 9p) is the most common gene mutated in familial melanoma


  • CDKN2A = tumor suppressor, encodes p14 and p16 which allow p53 and Rb respectively to function


  • Most common gene mutation = BRAF, associated more with sun-protected area MM; codes for a kinase, BRAF, and also associated with papillary thyroid carcinoma and colorectal carcinoma; 90 % of BRAF mutations are V600E (glutamic acid for valine)


  • Majority of melanomas have BRAF (60 %) or NRAS (20 %) mutations (would not expect in same tumor)


  • Increased c-KIT mutations in MM from mucosal, acral, and chronically sun-damaged skin; imatinib (Gleevec) is potential therapy


  • Patients with history of MM should have GYN, ophtho, and dental f/u (for screening of areas where melanoma may occur that dermatologists may not evaluate well)


  • Treatment for metastatic melanoma: Currently no truly effective treatment. Standard chemotherapy has included dacarbazine (DTIC) and IL-2 despite response rates of only 15–25 %


  • New treatments include:

    1.

    BRAF inhibitors: sorafenib (nonselective, and not very efficacious in trials), PLX4032/vemurafenib, inhibits BRAF with V600E mutation (these may increase keratoacanthoma-type SCCs, however)

     

    2.

    Ipilimumab, a monoclonal antibody against cytotoxic T-lymphocyte antigen 4 (CTLA-4), potentiates T-cell anti- tumor response

     

    3.

    Imatinib (Gleevec) – potential for patients with c-KIT mutation (acral and mucosal)

     

    4.

    Newest focus has been on MEK inhibitors in combination with BRAF inhibitors; also, PD-1 inhibitors (see also Basic Science: Genes in Melanoma)

     




  • NSAIDs/ASA may decrease melanoma incidence


  • Melanoma appears to occur more frequently on L > R (perhaps from sitting in car on driver’s side?)


  • Important immunohistochemistry stains:



    • S100 = sensitive, not specific



      • Stains melanocytes, dendritic cells, neural cells, adipocytes, sweat glands, breast epithelium


      • Good for desmoplastic MM


    • HMB-45 = specific, not sensitive



      • Stains only superficial


      • Poor staining in spindle cell/desmoplastic MM


      • Gradient pattern might help ddx MM vs. Spitz


    • Melan-A/MART-1 = current standard



      • Most sensitive/specific marker for demonstrating melanocytes


      • Target of cytotoxic cells; role in formation of type II melanosomes


      • May upstage MMIS


  • Surgical margins by depth (in general):



    • MMIS = 0.5 cm


    • MM <1 mm = 1 cm


    • MM <1–4 mm = 2 cm


    • MM >4 mm = 2–3 cm


I.

Superficial spreading



  • 60–70 % of melanomas

 

II.

Nodular



  • No radial growth phase, 15–30 %

 

III.

Acral lentiginous



  • 5–10 %


  • Noted in darker skin patients, not because increased incidence, but all other types decreased incidence

 

IV.

Lentigo maligna melanoma



  • 5–15 %, slow growing on sun-exposed skin

 

V.

Amelanotic



  • Ddx pyogenic granuloma, BCC, SCC, purple plums


  • May have worse prognosis, but also often with delays in diagnosis

 

VI.

Desmoplastic/Spindle cell melanoma



  • May have tendency to locally recur, but less likely to metastasize

 

VII.

Ocular



  • Melanocytes found in the posterior uveal tract; posterior uveal chamber MM can metastasize to liver (hematogenous spread)

 

VIII.

Mucosal

 

IX.

Melanoma in situ



  • Includes lentigo maligna

 

 


7.3 Adnexal Tumors






  • Note: some tumors appear to have either eccrine or apocrine derivation (may be controversial), but this is generally not clinically relevant


1.

Eccrine



  • Primary function of eccrine glands is thermoregulation; also electrolyte balance


  • Ketoconazole, griseofulvin, and chemotherapeutic agents may be secreted in sweat


  • Eccrine sweat = 99 % water plus electrolytes, secreted by merocrine (eccrine) secretion


  • Innervated by sympathetic postgangliotic innervation, but functionally cholinergic (neurotransmitter = acetylcholine)


(a)

Poroma



  • A papule or nodule, often on palms/soles, can be on scalp


  • Clinical ddx: pyogenic granuloma, amelanotic melanoma


  • Path: downward grown of blue basaloid cells with ducts


  • Three benign variants (and one malignant):


I.

Eccrine poroma (both epidermal and dermal)

 

II.

Hidroacanthoma simplex (epidermal)

 

III.

Dermal duct tumor (dermal)

 

IV.

Porocarcinoma

 

 

(b)

Syringoma



  • Typically around eyes, but can be on abdomen/thighs/genitals


  • Path: multiple small ducts in fibrous stroma, nests may resemble commas or tadpoles


  • Can be eruptive in Down syndrome

    Variants include:


I.

Clear cell syringoma



  • May be associated with DM

 

II.

Chondroid syringoma (aka mixed tumor)



  • Tubular/epithelial layers, mucoid stroma, Alcian blue (+)


  • Can see ghost cells (pink), but no basaloid cells, ddx pilomatricoma

 

 

(c)

Eccrine hidrocystoma



  • Glistening papule, typically infraorbital, see also Neoplastic: Cysts

 

(d)

Eccrine spiradenoma



  • In the painful tumor ddx


  • Actually thought to be apocrine-derived by most now

 

(e)

Clear cell hidradenoma (nodular hidradenoma)

 

(f)

Eccrine carcinoma

 

(g)

Other eccrine disorders

I.

Hyperhidrosis



  • Treatment = antiperspirants (aluminum chloride hexahydrate), glycopyrrolate, Botox, and last resort = surgery


1.

Frey’s syndrome (auriculotemporal syndrome or gustatory sweating)



  • Common after parotid surgery or trauma

 

 

II.

Hypohidrosis

1.

Hypohidrotic ectodermal dysplasia (HED)



  • Aka anhidrotic ectodermal dysplasia, Christ-Siemens-Touraine syndrome


  • Thin, sparse, or absent hair, missing or peg-shaped teeth, inability to sweat correctly


  • Primarily X-linked recessive


  • See also Alopecia: Non-scarring alopecia: Ectodermal dysplasias

 

 

III.

Bromhidrosis



  • Eccrine sweat is odorless; however, maceration can allow bacterial colonization, and apocrine sweat can be decomposed by bacteria


1.

Trimethylaminuria (TMA)



  • Known for causing “fishy”-odor


  • Inherited deficiency of FMO3 (flavin-containing monooxygenase-3)


  • Tx = avoid eggs, kidney, liver, fish in diet

 

 

IV.

Chromhidrosis (colored sweat)

 

V.

Miliaria



  • See also Vesiculobullous: Other

 

VI.

Uremic frost



  • Rarely, see uric acid deposits on skin in ESRD

 

 

 

2.

Apocrine



  • Apocrine gland variants: Moll’s glands on the eyelids, cerumen producing glands of inner ear, milk-producing apocrine glands


  • Apocrine glands secrete via decapitation secretion


  • Apocrine tumors can be associated with increased plasma cells


(a)

Cylindroma



  • Clinical: “turban tumors”


  • Path: “jigsaw puzzle,” well-circumscribed pieces, two cell populations, glassy rim


I.

Brooke-Spiegler syndrome



  • Mutation in CYLD (a tumor supressor), which encodes a deubiquitinating enzyme (a protease), which inhibits the NF-κB pathway


  • Cylindromas, trichoepitheliomas, and spiradenomas


  • See also Neoplastic: Syndromes with Multiple Tumors or Multiple Types of Tumors

 

 

(b)

Spiradenoma



  • Related to cylindromas; can see in Brooke-Spiegler


  • Path: Round “blue balls” in the dermis, but not as well circumscribed as jigsaw of cylindroma; 3 cell types = 1. pale, 2. dark, and 3. lymphocytes (this may be why it is painful)

 

(c)

Hidradenoma (hidradenoma papilliferum)



  • Seen in vulvar and perianal areas


  • Path = partially cystic with papillary and glandular areas, no epidermal connection

 

(d)

Apocrine adenoma

I.

Syringocystadenoma papilliferum



  • Presents as warty papule/plaque, may ooze serosanguinous fluid


  • Almost exclusively on head/neck, 1/3 occur in nevus sebaceus


  • Path = irregular papillary projections protrude into invagination of surface epithelium; stroma with plasma cell infiltrate, often an epidermal connection

 

 

(e)

Apocrine hidrocystoma



  • Clinical: glistening cystic papule, typically on the eyelid, see also Neoplastic: Cysts


  • Path = dilated apocrine gland on eyelid skin, shows decapitation secretion, lined by two layers of cells

 

(f)

Microcystic adnexal carcinoma (MAC)



  • Most commonly occurs on the upper lip, locally aggressive


  • Path: poorly circumscribed, deeply infiltrative (subcutaneous to even muscle) with perineural invasion

 

(g)

Extramammary Paget’s disease



  • Most commonly in groin, perianal, scrotum, vulva


  • 25–50 % associated with cutaneous malignancy


  • Path = atypical cells with abundant pale cytoplasm, can see Pagetoid spread

 

(h)

Syringoma (see eccrine)

 

(i)

Apocrine poroma

 

(j)

Apocrine carcinoma

 

 

3.

Sebaceous



  • Remember association with Muir-Torre; in particular, the sebaceous adenoma is a unique hallmark


  • Note: nevus sebaceus is not a sebaceous neoplasm


  • For more detail on sebum, see also Basic Science: Sebum


  • Sebaceous gland variants:



    • Eyelids: Mebomian glands (inflamed = chalazion); Glands of Zeis (superficial margin, inflamed = hordeolum/stye); Mnemonic: Mebomian almost rhymes with chalazion, Zeis almost with stye.


    • Areolae: Montgomery tubercles


    • Vermillion, buccal mucosa: Fordyce spots


    • Genitalia: Tyson’s glands


(a)

Sebaceous hyperplasia



  • Yellow delled papules on face/chest


  • Path: large sebaceous lobules grouped around a central dilated duct (all connected to hair follicle)

 

(b)

Sebaceous adenoma



  • The hallmark lesion of Muir-Torre syndrome (MLH1, MSH2 defect)


  • Path: multiple sharply demarcated sebaceous lobules, separated and compressed connective tissue septa; classically, approximately half of the cells are mature sebocytes.

 

(c)

Sebaceoma (sebaceous epithelioma)



  • On a spectrum with sebaceous adenoma (some controversy about how to distinguish), may be associated with Muir-Torre


  • Path: similar to sebaceous adenoma, classically with a majority of sebocytes undifferentiated/germinative and only scattered clusters of mature sebocytes

 

(d)

Sebaceous carcinoma



  • Classically on eyelid, though BCC more likely in this location


  • Path: may see Pagetoid spread

 

(e)

Muir-Torre syndrome
Oct 6, 2016 | Posted by in Dermatology | Comments Off on Neoplastic Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access